Résultats de votre recherche

Anani Olympio - Head of Actuarial and Artificial Intelligence Ethics - has a PhD in Management Sciences from Claude Bernard University Lyon 1 and PhD in Management Sciences from Institut de Science Financière et d'Assurances.

Jérôme Fournier - Vice President of Innovation, Services and Growth - has a Ph D in Materials and Composites from Claude Bernard University Lyon 1 and master in Philosophy from University of Wales, Swansea.

Olivier Bogillot - Head of General Medicines - a reçu un PhD in Health Economics de Claude Bernard University Lyon 1.

Jean-Arnaud Eyme - Chief Digital and Data Officer - a reçu un Master in Management, Administration and Business Management de Claude Bernard University Lyon 1.

Zakaria Asri - Chief Innovation Officer - a reçu un Master in Management de Claude Bernard University Lyon 1.

Nicolas Jullien - Global Head of Fixed Income - a reçu un Masters degree in Actuarial and Financial Sciences de Claude Bernard University Lyon 1.

Philippe Espiard - General Manager, Research and Development - a reçu un Doctorate, macromolecular materials de Claude Bernard University Lyon 1.

Christian Prothery - Regional Sales Manager, North and South France - a reçu un diplôme de Claude Bernard University Lyon 1.

Jean-Luc Lemercier - Director - a reçu un Doctorate de Claude Bernard University Lyon 1.

Isabelle Chanel - Research & Development Medical and Scientific Affairs Director - a reçu un Bachelor of Science in Analytical Chemistry de Claude Bernard University Lyon 1.

Jean-Christophe Bayssat - Deputy General Manager and Chief Pharmacist and Pharmaceutical Development Director - a reçu un Doctor in Pharmacy de Claude Bernard University Lyon 1.

Julien Moutte - Chief Technology Officer - a reçu un Bachelor in Computer Science de Claude Bernard University Lyon 1.

Patrick Perret - Audit Director - a reçu un diplôme de Claude Bernard University Lyon 1.

Jean-Yves Blay - Director - a reçu un PhD degree, Immune Effector Cells and Cytokines in Cance de Claude Bernard University Lyon 1.

Jean-Yves Blay - Director - a reçu un PhD degree, Immune Effector Cells and Cytokines in Cance de Claude Bernard University Lyon 1.

Patrick Ledjam - General Manager - a reçu un diplôme de Claude Bernard University Lyon 1.

Nicolas Jullien - Deputy Managing Director, Perial Investment and Development - a reçu un Masters degree in Actuarial and Financial Sciences de Claude Bernard University Lyon 1.